GammaTile® (GT) as a brachytherapy platform for rapidly growing brain metastasis.
Rajiv DharnipragadaClara FerreiraRena ShahMargaret ReynoldsKathryn DusenberyClark C ChenPublished in: Neuro-oncology advances (2023)
Our pilot experience suggests that GT offers favorable local control and safety profile in patients suffering from brain metastases that exhibit aggressive growth patterns and support the future investigation of this treatment paradigm.
Keyphrases
- brain metastases
- small cell lung cancer
- end stage renal disease
- ejection fraction
- newly diagnosed
- high dose
- chronic kidney disease
- radiation therapy
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- high throughput
- clinical trial
- randomized controlled trial
- locally advanced
- patient reported outcomes
- white matter
- low dose
- study protocol
- brain injury
- single cell